Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: Observations in a single hospital.
Sato
T
T
Hanaoka
R
R
Ohshima
M
M
Miwa
Y
Y
Okazaki
Y
Y
Yajima
N
N
Ishizashi
H
H
Matsumoto
M
M
Fujimura
Y
Y
Inokuma
S
S
D051722:ADAM Proteins / Q000037:antagonists & inhibitors / Q000097:blood*; D000071120:ADAMTS13 Protein; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood; D003240:Connective Tissue Diseases / Q000097:blood* / Q000150:complications / Q000453:epidemiology; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008875:Middle Aged; D011480:Protease Inhibitors / Q000097:blood*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood* / Q000150:complications / Q000453:epidemiology; D014841:von Willebrand Factor / Q000032:analysis*
D001323:Autoantibodies; D011480:Protease Inhibitors; D014841:von Willebrand Factor; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human